Researchers purchasing KPV for laboratory studies should verify the supplier operates under appropriate licensing (503B registration for compounding facilities) and that product labeling explicitly states for research use only to maintain regulatory compliance
Studies suggest that these injections may lower homocysteine levels, a substance that can increase the risk of heart disease
As one FDA official put it: We dont actually know with any certainty what it is. Those doubts didnt convince the committee, which voted 86 to recommend that BPC-157 compounding be allowed
Journal (Molecules, Nov 19, 2014, 19(11), 1906619077)
Dosage: 1000 mcg per week (split into 2-3 doses) via subcutaneous injection
Thank for great service Awesome people and superior products The process was very easy and I like that alcohol pads and syringes were provided